Acute myeloid leukemia (AML) is an aggressive cancer of the blood forming (hematopoietic) system. Due to the high patient variability of disease dynamics, risk-scoring is an important part of its clinical management. AML is characterized by impaired blood cell formation and the accumulation of so-called leukemic blasts in the bone marrow of patients. Recently, it has been proposed to use counts of blood-producing (hematopoietic) stem cells (HSCs) as a biomarker for patient prognosis. In this work, we use a non-linear mathematical model to provide mechanistic evidence for the suitability of HSC counts as a prognostic marker. Using model analysis and computer simulations, we compare different risk-scores involving HSC quantification. We propose and validate a simple approach to improve risk prediction based on HSC and blast counts measured at the time of diagnosis.
Using mathematical models to improve risk-scoring in acute myeloid leukemia
Note: This paper is part of the Focus Issue on Dynamical Disease: A Translational Perspective.
Thomas Stiehl; Using mathematical models to improve risk-scoring in acute myeloid leukemia. Chaos 1 December 2020; 30 (12): 123150. https://doi.org/10.1063/5.0023830
Download citation file: